Publications (102) Publications in which a researcher has participated View referenced research data.

filter_list Microbiology (medical)

2023

  1. Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 4, pp. 238-242

  2. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 360-370

  3. Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 430-435

2022

  1. Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study

    Infectious Diseases and Therapy, Vol. 11, Núm. 4, pp. 1505-1519

  2. Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives

    Biological Reviews, Vol. 97, Núm. 3, pp. 1005-1037

  3. Molecular Analysis of the Contribution of Alkaline Protease A and Elastase B to the Virulence of Pseudomonas aeruginosa Bloodstream Infections

    Frontiers in Cellular and Infection Microbiology, Vol. 11

  4. Multicenter Performance Evaluation of MALDI-TOF MS for Rapid Detection of Carbapenemase Activity in Enterobacterales: The Future of Networking Data Analysis With Online Software

    Frontiers in Microbiology, Vol. 12

  5. Rapid Identification and Classification of Pathogens That Produce Carbapenemases and Cephalosporinases with a Colorimetric Paper-Based Multisensor

    Analytical Chemistry, Vol. 94, Núm. 26, pp. 9442-9449

2020

  1. Clinically relevant epithelial lining fluid concentrations of meropenem with ciprofloxacin provide synergistic killing and resistance suppression of hypermutable pseudomonas aeruginosa in a dynamic biofilm model

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 7

  2. From CLSI to EUCAST, a necessary step in Spanish laboratories

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 2, pp. 79-83

  3. Minimum information guideline for spectrophotometric and fluorometric methods to assess biofilm formation in microplates

    Biofilm, Vol. 2

  4. Nosocomial outbreak linked to a flexible gastrointestinal endoscope contaminated with an amikacin-resistant ST17 clone of Pseudomonas aeruginosa

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 39, Núm. 10, pp. 1837-1844

  5. Pathogenic characteristics of Pseudomonas aeruginosa bacteraemia isolates in a high-endemicity setting for ST175 and ST235 high-risk clones

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 39, Núm. 4, pp. 671-678

  6. Rapid Detection of Pseudomonas aeruginosa Biofilms via Enzymatic Liquefaction of Respiratory Samples

    ACS Sensors, Vol. 5, Núm. 12, pp. 3956-3963

  7. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187

  8. Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study

    International Journal of Antimicrobial Agents, Vol. 55, Núm. 2

  9. Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections

    Clinical Microbiology and Infection, Vol. 26, Núm. 3, pp. 351-357

2019

  1. Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: Results from a Spanish nationwide survey

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 11, pp. 3217-3220

  2. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 4

  3. Comparative analysis of peptidoglycans from pseudomonas aeruginosa isolates recovered from chronic and acute infections

    Frontiers in Microbiology, Vol. 10, Núm. AUG